SCHEMBL22096835

SCHEMBL22096835

CCc1cccc(F)c1-c1ncc[nH]1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 2/20 0.49
HTR1A P08908 1/20 0.49
MC4R P32245 1/20 0.40
NISCH Q9Y2I1 2/20 0.40
MTOR P42345 1/20 0.40
ADK P55263 1/20 0.40
F2RL1 P55085 7/20 0.38
ADORA2A P29274 2/20 0.38
ADORA1 P30542 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP19A1 P11511 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
ALDH1A1 P00352 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
PDE4A P27815 1/20 0.35
PDE4B Q07343 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11124417 0.89 TAAR1 (0.56) TAAR1HTR1ANISCHMTORADK
Hydrochloric Acid SCHEMBL29265354 0.87 TAAR1 (0.54) TAAR1HTR1ANISCHMTORADK
SCHEMBL6002691 0.83 NISCH (0.50) TAAR1MC4RNISCHMTORADK
SCHEMBL19782078 0.82 NISCH (0.44) TAAR1MC4RNISCHMTORADK
SCHEMBL27764041 0.76 TAAR1 (0.45) TAAR1HTR1ANISCHMTORADK
SCHEMBL28829249 0.76 NISCH (0.43) MC4RNISCHMTORADKF2RL1
SCHEMBL19769010 0.75 TAAR1 (0.48) TAAR1MC4RNISCHMTORADK
SCHEMBL21883582 0.75 NISCH (0.40) TAAR1MC4RNISCHMTORADK
SCHEMBL6759199 0.74 TAAR1 (0.43) TAAR1HTR1ANISCHMTORADK
SCHEMBL17304239 0.73 CSNK1A1 (0.53) TAAR1HTR1AMC4RNISCHMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10875839-B2 Somatostatin modulators and uses thereof Crinetics Pharmaceuticals, Inc. (US) 2020-12-29 US disclosed
US-20200190053-A1 SOMATOSTATIN MODULATORS AND USES THEREOF Crinetics Pharmaceuticals, Inc. 2020-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200190053-A1 SOMATOSTATIN MODULATORS AND USES THEREOF SSTR5, SSTR2, SSTR4 TAAR1 415/4885HTR1A 245/4885MC4R 35/4885
US-10875839-B2 Somatostatin modulators and uses thereof SSTR5, SSTR2, SSTR4 TAAR1 415/4885HTR1A 245/4885MC4R 35/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.